Showing results (211-220 of 293) with videos related to

Sort By:
Pageof 30
British Journal of Haematology|June 25, 2016
Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patientsHeiko-Manuel Teltschik, Frank Heinzelmann, Bernd Gruhn, et al.
Radiation Oncology (London, England)|July 31, 2024
Quantitative PSMA-PET parameters in localized prostate cancer: prognostic and potential predictive valueStephanie Bela Andela, Holger Amthauer, Christian Furth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 25, 2019
Partial breast irradiation with the 1.5 T MR-Linac: First patient treatment and analysis of electron return and stream effectsMarcel Nachbar, David Mönnich, Simon Boeke, et al.
Clinical and Translational Radiation Oncology|March 6, 2019
Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patientsAnna Bandurska-Luque, Steffen Löck, Robert Haase, et al.
The Journal of Clinical Investigation|June 10, 2010
PINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1alphaIris Eke, Ulrike Koch, Stephanie Hehlgans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2016
Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumoursChristina Jentsch, Ralf Bergmann, Kerstin Brüchner, et al.
Journal of Translational Medicine|August 26, 2023
Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenograftsLydia Koi, Verena Bitto, Corina Weise, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 23, 2015
Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsivenessApostolos Menegakis, Chiara De Colle, Ala Yaromina, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 9, 2018
FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patientsAnna Bandurska-Luque, Steffen Löck, Robert Haase, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
Identification of Patient Benefit From Proton Therapy for Advanced Head and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue Complication Probability AnalysisAnnika Jakobi, Anna Bandurska-Luque, Kristin Stützer, et al.
Pageof 30